Neoadjuvant endocrine therapy ‘a reasonable option’ for ER-positive breast cancer
Endocrine therapy should be reconsidered as a potential option in the neoadjuvant setting for localised oestrogen receptor-positive breast cancer, say the authors of a meta-analysis.
Source: MedWire News - Category: Consumer Health News Tags: Breast cancer Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Health | Neoadjuvant Therapy